- Login
- Register & Subscribe
- Language: EN FR DE
Research & University News
Bioengineered trachea is successfully transplanted
Wednesday 19 November 2008
Paolo Macchiarini, head of thoracic surgery at the Hospital Clinic in Barcelona, Spain and colleagues have reported the results of a trachea transplant into a woman with tuberculosis using tissue from a donor which was repopulated with stem and epithelial cells from the recipient. This is understood to be the first ever trachea transplant and the first ever tissue transplant to be performed without the use of immunosuppressive drugs.
Location
Spain
Cellartis, Novo Nordisk and Lund University to research diabetes treatment using embryonic stem cells
Thursday 30 October 2008
A long-standing collaboration among Cellartis AB, the Hagedorn Research Institute of Novo Nordisk, and Professor Henrik Semb of Lund University into diabetes has been upgraded with a view to developing a new cell therapy for the treatment of type 1 diabetes.
Location
Sweden
Cambridge University highlights data for alemtuzumab in MS
Thursday 23 October 2008
The University of Cambridge is highlighting the results of a Phase 2 study of the monoclonal antibody alemtuzumab which, it says, shows the drug has promise for treating people with multiple sclerosis.
Location
United Kingdom
See map: Google Maps
New class of antibiotics may subdue MRSA
Friday 19 September 2008
Research published in the journal, Science, and financially supported by the Wellcome Trust, describes how a new class of antibiotics could be developed to treat multi-drug resistant Staphylococcus aureus (MRSA).
Location
United Kingdom
See map: Google Maps
European Institute of Innovation and Technology appointments
Thursday 14 August 2008
The European Institute of Innovation and Technology, based in Budapest, Hungary, has appointed its first 18-person governing board. The institute is a new European Union organisation that will promote new technologies in the physical, social and life sciences.
Location
Hungary
GlaxoSmithKline collaborates with Harvard University on stem cell research
Monday 28 July 2008
Four days after announcing its first ever research agreement with the University of Cambridge in the UK, GlaxoSmithKline has disclosed a five-year collaboration with the Harvard Stem Cell Institute in the US to discover new therapies based on stem cell science.
Location
United Kingdom
See map: Google Maps
GSK and Cambridge University in research collaboration
Thursday 24 July 2008
GlaxoSmithKline has signed its first ever research agreement with the University of Cambridge in the UK to develop a novel, centrally-acting agent with therapeutic potential for obesity and addictive disorders. Financial terms were not disclosed.
Location
United Kingdom
See map: Google Maps
Modern Biosciences to invest in vascular disrupting agent
Wednesday 9 July 2008
The UK drug development company, Modern Biosciences, has entered into an exclusive agreement with the University of Bradford, also of the UK, to develop a vascular disrupting agent for cancer. Financial terms were not disclosed.
Location
United Kingdom
See map: Google Maps
Cancer Research UK scientists identify protein target for vaccines
Saturday 24 May 2008
Researchers from Cancer Research UK have identified a new protein target that could be used to produce vaccine therapies for cancer. Their findings are reported in the 22 May 2008 issue of The Journal of Clinical Investigation.
Location
United Kingdom
See map: Google Maps
Jenner Institute tests malaria vaccine in Phase 1 trial
Tuesday 12 February 2008
Scientists at the University of Oxford’s Jenner Institute have started a Phase 1 trial for a new candidate vaccine against malaria, which is designed to stimulate an immune response to the malaria parasite by using a genetically modified chimpanzee adenovirus.
Location
United Kingdom
See map: Google Maps
Select a News Category
Recent Appointments
Tim Edwards elected chairman of BIA
Tuesday September 7 2010
Index Ventures appoints antibody expert as partner
Friday September 3 2010
Colin Stewart appointed CEO at Amarin
Friday August 20 2010
Karl Keegan nominated as CFO of Pharming
Friday August 20 2010
Axel Müller becomes CEO at SkyePharma
Thursday August 19 2010